We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Aetna Loses Bid To Re-Enter Pfizer Off-Label MDL

Law360 (April 20, 2011, 8:03 PM EDT) -- A Massachusetts judge on Wednesday refused to reconsider Aetna Inc.'s suit accusing Pfizer Inc. of improperly marketing the epilepsy drug Neurontin in violation of racketeering and competition laws.

Judge Patti B....
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.